Table 5 shows relevant metrics for prostate and organs at risk for prescription of 60 and 62 Gy in 20 fractions. Median and interquartile ranges are shown
| Â | Prostate volume | PTV Prostate | Bladder | Rectum | |||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
Prescription Dose | Â | D98% | D2% | D3% | D15% | D30% | D0.01% | D5% | D22% | D38% | D57% |
60 Gy | 40.8 (29.3–46.3) | 56.2 (56.2–56.8) | 61.4 (61.2–61.9) | 58.3 (51.3–58.9) | 38.0 (32.1–42.8) | 23.2 (19.8–26.5) | 59.7 (59.1–60.0) | 54.3 (51.6–56.5) | 34.1 (30.8–36.3) | 15.1 (8.3–18.6) | 8.1 (6.8–8.3) |
62 Gy | 60.0 (38.7–88.7) | 58.3 (58.1–58.4) | 63.8 (63.5–64.0) | 58.1 (54.0–59.0) | 33.1 (31.9–37.1) | 20.0 (17.0–22.3) | 59.9 (59.8–60.1) | 50.9 (49.3–55.0) | 26.0 (23.5–33.6) | 15.6 (13.8–18.9) | 9.1 (6.4–10.8) |